Literature DB >> 6744315

Morphological, biological, and biochemical characteristics of human bladder transitional cell carcinomas grown in tissue culture and in nude mice.

A A Kyriazis, A P Kyriazis, W B McCombs, W D Peterson.   

Abstract

The morphological, biological, biochemical, and karyotypic characteristics of four human bladder transitional cell carcinoma lines, SW-780, SW-800, SW-1738, and SW-1710, were investigated. In tissue culture, each cell line presented a distinct phenotypic expression. All but line SW-1710 grew when transplanted in the nude mouse. Light and electron microscopic studies showed morphological characteristics similar to the tumors of origin, being independent of the passages in tissue culture medium, tumor cell extracts, and the plasma of nude mouse-grown tumors, showing isoenzyme quantitative distribution typical for each cell line. In addition, each cell line exhibited a unique genetically determined enzyme phenotypic profile which, along with the karyotypic analysis, makes their identification feasible. These characteristics make the described tumor lines a valuable tool in studying various aspects of the biology of human bladder transitional cell carcinoma.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6744315

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  11 in total

1.  Experimental studies of chemosensitivity testing of urothelial cancer grown in nude mice.

Authors:  A P Kyriazis; A A Kryiazis; A Yagoda
Journal:  Urol Res       Date:  1990

2.  Human papillomavirus sequences are not detectable by Southern blotting or general primer-mediated polymerase chain reaction in transitional cell tumours of the bladder.

Authors:  M A Knowles
Journal:  Urol Res       Date:  1992

Review 3.  Cadmium as a possible cause of bladder cancer: a review of accumulated evidence.

Authors:  Molka Feki-Tounsi; Amel Hamza-Chaffai
Journal:  Environ Sci Pollut Res Int       Date:  2014-06-04       Impact factor: 4.223

4.  Metabolism and growth inhibitory activity of cranberry derived flavonoids in bladder cancer cells.

Authors:  Jeevan K Prasain; Rajani Rajbhandari; Adam B Keeton; Gary A Piazza; Stephen Barnes
Journal:  Food Funct       Date:  2016-09-14       Impact factor: 5.396

5.  Increased expression of transcription factor TFAP2α correlates with chemosensitivity in advanced bladder cancer.

Authors:  Iver Nordentoft; Lars Dyrskjøt; Julie S Bødker; Peter J Wild; Arndt Hartmann; Simone Bertz; Jan Lehmann; Torben F Orntoft; Karin Birkenkamp-Demtroder
Journal:  BMC Cancer       Date:  2011-04-14       Impact factor: 4.430

6.  Functional analysis of the mismatch repair system in bladder cancer.

Authors:  T Thykjaer; M Christensen; A B Clark; L R Hansen; T A Kunkel; T F Ørntoft
Journal:  Br J Cancer       Date:  2001-08-17       Impact factor: 7.640

7.  NKG2D is a Key Receptor for Recognition of Bladder Cancer Cells by IL-2-Activated NK Cells and BCG Promotes NK Cell Activation.

Authors:  Eva María García-Cuesta; Sheila López-Cobo; Mario Álvarez-Maestro; Gloria Esteso; Gema Romera-Cárdenas; Mercedes Rey; Robin L Cassady-Cain; Ana Linares; Alejandro Valés-Gómez; Hugh Thomson Reyburn; Luis Martínez-Piñeiro; Mar Valés-Gómez
Journal:  Front Immunol       Date:  2015-06-08       Impact factor: 7.561

8.  Identification of long non-coding RNAs that stimulate cell survival in bladder cancer.

Authors:  Aleksandra M Dudek; Sabrina J Boer; Nanda Boon; J Alfred Witjes; Lambertus A L M Kiemeney; Gerald W Verhaegh
Journal:  Oncotarget       Date:  2017-05-23

9.  Reduced expression of TGF beta is associated with advanced disease in transitional cell carcinoma.

Authors:  L M Coombs; D A Pigott; M E Eydmann; A J Proctor; M A Knowles
Journal:  Br J Cancer       Date:  1993-03       Impact factor: 7.640

10.  Isolation and characterization of a novel human bladder cancer cell line: BK10.

Authors:  K M Roberson; D R Yancey; H Padilla-Nash; D W Edwards; W Nash; S Jacobs; G M Padilla; W A Larchian; C N Robertson
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998 Jul-Aug       Impact factor: 2.723

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.